Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

Micha R, Imamura F, Wyler von Ballmoos M, Solomon DH, Hernán MA, Ridker PM, Mozaffarian D.

Am J Cardiol. 2011 Nov 1;108(9):1362-70. doi: 10.1016/j.amjcard.2011.06.054. Epub 2011 Aug 17. Review.

3.

Cardiovascular risk in rheumatoid arthritis: how to lower the risk?

van Breukelen-van der Stoep DF, Klop B, van Zeben D, Hazes JM, Castro Cabezas M.

Atherosclerosis. 2013 Nov;231(1):163-72. doi: 10.1016/j.atherosclerosis.2013.09.006. Epub 2013 Sep 20. Review.

PMID:
24125429
4.

Methotrexate for treating rheumatoid arthritis.

Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD000957. doi: 10.1002/14651858.CD000957.pub2. Review.

PMID:
24916606
5.

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.

Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S.

JAMA. 2011 Jun 22;305(24):2525-31. doi: 10.1001/jama.2011.878.

PMID:
21693740
6.

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ.

Rheumatology (Oxford). 2010 Feb;49(2):295-307. doi: 10.1093/rheumatology/kep366. Epub 2009 Nov 27. Review.

PMID:
19946022
7.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2013 May 31;(5):CD000951. doi: 10.1002/14651858.CD000951.pub2. Review.

PMID:
23728635
8.

Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.

Barnabe C, Martin BJ, Ghali WA.

Arthritis Care Res (Hoboken). 2011 Apr;63(4):522-9. doi: 10.1002/acr.20371. Review.

9.
10.

Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.

Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, Herrinton LJ, Graham DJ, Kowal MK, Kuriya B, Liu L, Griffin MR, Lewis JD, Rassen JA.

Am J Med. 2013 Aug;126(8):730.e9-730.e17. doi: 10.1016/j.amjmed.2013.02.016.

11.

Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Conway R, Low C, Coughlan RJ, O'Donnell MJ, Carey JJ.

Arthritis Rheumatol. 2014 Apr;66(4):803-12. doi: 10.1002/art.38322.

12.

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.

Arthritis Rheum. 2006 Dec;54(12):3790-8.

13.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

14.

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Katchamart W, Trudeau J, Phumethum V, Bombardier C.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008495. doi: 10.1002/14651858.CD008495. Review.

PMID:
20393970
15.
16.

Does treatment of psoriasis reduce the risk of cardiovascular disease?

Churton S, Brown L, Shin TM, Korman NJ.

Drugs. 2014 Feb;74(2):169-82. doi: 10.1007/s40265-013-0173-5. Review.

PMID:
24420963
17.
18.

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.

Ahlehoff O, Skov L, Gislason G, Lindhardsen J, Kristensen SL, Iversen L, Lasthein S, Gniadecki R, Dam TN, Torp-Pedersen C, Hansen PR.

J Intern Med. 2013 Feb;273(2):197-204. doi: 10.1111/j.1365-2796.2012.02593.x. Epub 2012 Oct 11.

19.

Insights on methotrexate in psoriatic disease.

Greb JE, Goldminz AM, Gottlieb AB.

Clin Immunol. 2016 Nov;172:61-64. doi: 10.1016/j.clim.2016.07.008. Epub 2016 Jul 25.

PMID:
27455859
20.

Supplemental Content

Support Center